Upload
hester-benson
View
217
Download
0
Embed Size (px)
Citation preview
Asthma Management
Fine TuningMaximum control with minimum medication
Start with mild asthma and work up the scale (BTS/SIGN 2004)
Fine Tuning
Asthma control means:-Minimal symptoms during day and night
-Minimal need for reliever medication-No exacerbations
-No limitation of physical activity
-Normal lung function (FEV1 and/or PEF >80% predicted or best)
Asthma Management
Fine TuningBefore initiating a new drug therapy:
-Check compliance with existing therapies
-Check inhaler technique ( Reconsider inhaler delivery system)
-Eliminate trigger factors
Asthma Management
Fine Tuning
Asthma Management
Step-wise approachStep-wise approach
AdultsAdults ChildrenChildren5-125-12 YearsYears
ChildrenChildren < <55 YearsYears
55 stepssteps 55 stepssteps 44 stepssteps
Asthma Management
Step 1:Mild intermittent asthma
Step 2:Introduction of regular preventer therapy
Step 3:Add-on therapy
Step 4:Poor control on moderate dose of inhaled steroids + Add on
Step 5:Use of oral steroids
Adults
Preventers: Inhaled corticosteroids (ICS)• 1st Choice Moderate Dose: Adults 200-800 mcg/day
Children 200-400 mcg/day
•BDP= Becotide (Beclomethasone Dipropionate) = Pulmicort (Budesonide)
•Flexotide (Fluticasone) ½ dose of BDP
High Dose ICS Adults 2000 mcg/dayChildren 800
mcg/day
Asthma Management
Add-On therapy
• 1st Choice LABA Adults/ Children 5-12 years
•LABA should not be used without ICS
• Others•2nd choice: LTRAs
•3rd choice: SR Theophylline•4rth choice: Oral LABA ( SR Be agonists tab) S.E
Asthma Management
Step 1: Mild intermittent asthma-Prescribe inhaled short-acting 2 agonist as short term reliever
therapy for all patients with symptomatic asthma
-Review asthma management in patients with high usage of inhaled short acting 2 agonists
Asthma Management
Step 2: Introduction of regular preventer
therapy when?Recent exacerbations
Nocturnal asthma
Impaired lung function
Using inhaled B2 agonist >once a day
Using inhaled B2 agonists > 3 times per week
Asthma Management
Step 2: Introduction of regular preventer
therapy Inhaled steroids are the 1st line preventers
Give inhaled steroids initially twice daily
If good control, once a day inhaled steroids at the same
total daily dose
Asthma Management
Step 2: Introduction of regular preventer
therapyStart patients at inhaled steroid dose appropriate to
disease severity
Adults: 400 mcg per day
Children 5-12 years: 200 mcg per day
Children under 5 years: higher doses may be required
to ensure consistent drug delivery
Use lowest dose at which effective control is maintained
Monitor children’s height on a regular basis
Asthma Management
Poor controlStill symptoms or
Sleep disturbance or
Restriction of activity
Despite use of regular inhaled steroid + PRN bronchodilator
Asthma Management
Poor control – Therapeutic options 1) check compliance
2) check inhaler technique3) Add LABA 1st Choice: Adults/ children 5-12
(in children <5 years LTRAs preferred)4) Suboptimal or no response : → dose of
inhaled steroid (800 mcg adult, 400 mcg children via spacer device
5) Poor control persist→ consider additional therapy: LTRAs, SR Theophylline or SR oral B 2 agonist +
Increase Inhaled steroid to 2000 mcg/day6) Oral steroids
Asthma Management
Step 3: Add-on therapy
Inadequate control on low dose inhaled steroidsInadequate control on low dose inhaled steroids
Asthma Management
Step 3: Add-on therapy
Inadequate control on low dose inhaled steroids
Add inhaled long-acting ßAdd inhaled long-acting ß2 2 agonist (LABA)agonist (LABA)
Asthma Management
Step 3: Add-on therapy
Inadequate control on low dose inhaled steroids
Assess control of asthmaAssess control of asthma
Add inhaled long-acting ß2 agonist (LABA)
Asthma Management
Step 3: Add-on therapy
Good response to Good response to LABA:LABA:• Continue LABAContinue LABA
Inadequate control on low dose inhaled steroids
Assess control of asthma
Add inhaled long-acting ß2 agonist (LABA)
Benefit from LABA but control Benefit from LABA but control still inadequate:still inadequate:
• Continue LABAContinue LABA• Increase inhaled steroid dose to Increase inhaled steroid dose to
800mcg/day (adults) and 800mcg/day (adults) and 400mcg/day (children 5-12 years)400mcg/day (children 5-12 years)
No response to LABA:No response to LABA:• Stop LABAStop LABA• Increase inhaled steroid dose Increase inhaled steroid dose
to 800mcg/day (adults) and to 800mcg/day (adults) and 400mcg/day (children400mcg/day (children5-12 years)5-12 years)
Asthma Management
Good response to LABA:• Continue LABA
Inadequate control on low dose inhaled steroids
Add inhaled long-acting ß2 agonist (LABA)
Benefit from LABA but control still inadequate:• Continue LABA• Increase inhaled steroid dose to
800mcg/day (adults) and 400mcg/day (children 5-12 years)
Control still inadequate:Control still inadequate:• Trial of other add-on therapy, Trial of other add-on therapy,
e.g. leukotriene receptor e.g. leukotriene receptor antagonist or theophyllineantagonist or theophylline
No response to LABA:• Stop LABA• Increase inhaled steroid dose
to 800mcg/day (adults) and 400mcg/day (children5-12 years)
Assess control of asthma
Asthma Management
Step 3
Inadequate control on low dose inhaled steroids
If control still inadequate If control still inadequate go to Step 4go to Step 4
Add inhaled long-acting ß2 agonist (LABA)
Benefit from LABA but control still inadequate:• Continue LABA and• Increase inhaled steroid dose to
800mcg/day (adults) and 400mcg/day (children 5-12 years)
Control still inadequate:• Trial of other add-on therapy,
e.g. leukotriene receptor antagonist or theophylline
If control still inadequate go If control still inadequate go to Step 4to Step 4
Assess control of asthma
No response to LABA:• Stop LABA• Increase inhaled steroid dose
to 800mcg/day (adults) and 400mcg/day (children5-12 years)
Good response to LABA:• Continue LABA
Asthma Management
Step 3
Step 4: poor control on moderate dose of
inhaled steroids + Add on inhaled steroids to 2000 mcg/day (adult) or 800 mcg/day
(children)
LTRAs OR SR Theophylline OR Oral SR B2 agonist
Consider referring to specialist care before proceeding to step 5
Asthma Management
Step 5: Use of oral steroidsMaintenance course (long term)
Plus drugs in step 4
Asthma Management
Step 1: Mild intermittent asthmaStep 1: Mild intermittent asthma
Inhaled short acting ßInhaled short acting ß22 agonist as required agonist as required
Stepwise management ofStepwise management ofasthma inasthma in adultsadults
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Stepwise management ofStepwise management ofasthma in asthma in adultsadults
Step 2: Regular preventer therapyStep 2: Regular preventer therapy
Add inhaled steroid 200-800mcg/day *Add inhaled steroid 200-800mcg/day *400mcg is an appropriate starting dose for many patients400mcg is an appropriate starting dose for many patients
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 1: Mild intermittent asthma
Start at dose of inhaled Start at dose of inhaled steroid appropriate to steroid appropriate to severity of disease.severity of disease.
* BDP or equivalent* BDP or equivalent
Stepwise management ofStepwise management ofasthma in asthma in adultsadults
Step 3: Add-on therapysStep 3: Add-on therapys
1. Add inhaled long-acting ß1. Add inhaled long-acting ß22 agonist (LABA) agonist (LABA)
2. Assess control of asthma:2. Assess control of asthma:• goodgood response to LABAresponse to LABA – continue LABA – continue LABA• benefit from LABA but control still inadequatebenefit from LABA but control still inadequate – continue LABA and – continue LABA and
increase inhaled steroid dose to 800mcg/day * (if not already on this dose)increase inhaled steroid dose to 800mcg/day * (if not already on this dose)• no response to LABAno response to LABA – stop LABA and increase inhaled steroid to – stop LABA and increase inhaled steroid to
800mcg/day *. If control still inadequate, institute trial of other therapies800mcg/day *. If control still inadequate, institute trial of other therapies(e.g. leukotriene receptor antagonist or SR theophylline)(e.g. leukotriene receptor antagonist or SR theophylline)
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 1: Mild intermittent asthma
Step 2: Regular preventer therapy Start at dose of inhaled Start at dose of inhaled steroid appropriate to steroid appropriate to severity of disease.severity of disease.
* BDP or equivalent* BDP or equivalent
Stepwise management ofStepwise management ofasthma in asthma in adultsadults
Step 4: Persistent poor controlStep 4: Persistent poor control
Consider trials of:Consider trials of:• increasing inhaled steroid up to 2000mcg/day *increasing inhaled steroid up to 2000mcg/day *• addition of fourth drug (e.g. leukotriene receptor addition of fourth drug (e.g. leukotriene receptor
antagonist, SR theophylline, ßantagonist, SR theophylline, ß22 agonist tablet) agonist tablet)
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 1: Mild intermittent asthma
Step 3: Add-on therapy
Step 2: Regular preventer therapy Start at dose of inhaled Start at dose of inhaled steroid appropriate to steroid appropriate to severity of disease.severity of disease.
* BDP or equivalent* BDP or equivalent
Stepwise management ofStepwise management ofasthma in asthma in adultsadults
Step 5: Continuous or frequent use of oral steroidsStep 5: Continuous or frequent use of oral steroids
Use daily steroid tablet Use daily steroid tablet in lowest dose providing adequate controlin lowest dose providing adequate controlMaintain high dose inhaled steroid at 2000mcg/day *Maintain high dose inhaled steroid at 2000mcg/day *Consider other treatments to minimise the use of steroid tabletsConsider other treatments to minimise the use of steroid tabletsRefer patient for specialist careRefer patient for specialist care
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 1: Mild intermittent asthma
Step 3: Add-on therapy
Step 2: Regular preventer therapy Start at dose of inhaled Start at dose of inhaled steroid appropriate to steroid appropriate to severity of disease.severity of disease.
* BDP or equivalent* BDP or equivalent
Step 4: Persistent poor control
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Stepwise management ofStepwise management ofasthma in asthma in adultsadults
Step 1: Mild intermittent asthmaStep 1: Mild intermittent asthma
Step 5: Continuous or frequent Step 5: Continuous or frequent use of oral steroidsuse of oral steroids
Step 4: Persistent poor controlStep 4: Persistent poor control
Step 3: Add-on therapyStep 3: Add-on therapy
Step 2: Regular preventer therapyStep 2: Regular preventer therapy
Stepwise management ofStepwise management ofasthma in children aged asthma in children aged 5-12 years5-12 years
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 1: Mild intermittent asthmaStep 1: Mild intermittent asthma
Inhaled short acting ßInhaled short acting ß22 agonist as required agonist as required
Stepwise management ofStepwise management ofasthma in children aged asthma in children aged 5-12 years5-12 years
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 2: Regular preventer therapyStep 2: Regular preventer therapy
Add inhaled steroid 200-400mcg/day *Add inhaled steroid 200-400mcg/day *(other preventer drug if inhaled steroid cannot be used)(other preventer drug if inhaled steroid cannot be used)200mcg is an appropriate starting dose for many patients200mcg is an appropriate starting dose for many patients
Step 1: Mild intermittent asthma
Start at dose of inhaled Start at dose of inhaled steroid appropriate to steroid appropriate to severity of disease.severity of disease.
* BDP or equivalent* BDP or equivalent
Stepwise management ofStepwise management ofasthma in children aged asthma in children aged 5-12 years5-12 years
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 3: Add-on therapyStep 3: Add-on therapy
1. Add inhaled long-acting ß1. Add inhaled long-acting ß22 agonist (LABA) agonist (LABA)
2. Assess control of asthma:2. Assess control of asthma:• goodgood response to LABAresponse to LABA – continue LABA. – continue LABA.• benefit from LABA but control still inadequatebenefit from LABA but control still inadequate – continue LABA and – continue LABA and
increase inhaled steroid dose to 400mcg/day * (if not already on this dose).increase inhaled steroid dose to 400mcg/day * (if not already on this dose).• no response to LABAno response to LABA – stop LABA and increase inhaled steroid to – stop LABA and increase inhaled steroid to
400mcg/day *. If control still inadequate, institute trial of other therapies 400mcg/day *. If control still inadequate, institute trial of other therapies (e.g. leukotriene receptor antagonist or SR theophylline).(e.g. leukotriene receptor antagonist or SR theophylline).
Step 1: Mild intermittent asthma
Step 2: Regular preventer therapy Start at dose of inhaled Start at dose of inhaled steroid appropriate to steroid appropriate to severity of disease.severity of disease.
* BDP or equivalent* BDP or equivalent
Stepwise management ofStepwise management ofasthma in children aged asthma in children aged 5-12 years5-12 years
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 4: Persistent poor controlStep 4: Persistent poor control
Increase inhaled steroid up to 800mcg/day *Increase inhaled steroid up to 800mcg/day *
Step 1: Mild intermittent asthma
Step 3: Add-on therapy
Step 2: Regular preventer therapy Start at dose of inhaled Start at dose of inhaled steroid appropriate to steroid appropriate to severity of disease.severity of disease.
* BDP or equivalent* BDP or equivalent
Stepwise management ofStepwise management ofasthma in children aged asthma in children aged 5-12 years5-12 years
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 5: Continuous or frequent use of oral steroidsStep 5: Continuous or frequent use of oral steroids
Use daily steroid tablet Use daily steroid tablet in lowest dose providing adequate controlin lowest dose providing adequate controlMaintain high dose inhaled steroid at 800mcg/day *Maintain high dose inhaled steroid at 800mcg/day *Refer patient to respiratory paediatricianRefer patient to respiratory paediatrician
Step 1: Mild intermittent asthma
Step 3: Add-on therapy
Step 2: Regular preventer therapy Start at dose of inhaled Start at dose of inhaled steroid appropriate to steroid appropriate to severity of disease.severity of disease.
* BDP or equivalent* BDP or equivalent
Step 4: Persistent poor control
Stepwise management ofStepwise management ofasthma in children aged asthma in children aged 5-12 years5-12 years
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 1: Mild intermittent asthmaStep 1: Mild intermittent asthma
Step 5: Continuous or frequent Step 5: Continuous or frequent use of oral steroidsuse of oral steroids
Step 4: Persistent poor controlStep 4: Persistent poor control
Step 3: Add-on therapyStep 3: Add-on therapy
Step 2: Regular preventer therapyStep 2: Regular preventer therapy
Stepwise management ofStepwise management ofasthma in children asthma in children underunder 5 years5 years
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 1: Mild intermittent asthmaStep 1: Mild intermittent asthma
Inhaled short acting ßInhaled short acting ß22 agonist as required agonist as required
Stepwise management ofStepwise management ofasthma in children asthma in children under 5 yearsunder 5 years
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 2: Regular preventer therapyStep 2: Regular preventer therapy
Add inhaled steroid 200-400mcg/day * Add inhaled steroid 200-400mcg/day * ††
(leukotriene receptor antagonist if inhaled steroid cannot be used)(leukotriene receptor antagonist if inhaled steroid cannot be used)
Step 1: Mild intermittent asthma
Start at dose of inhaled steroid Start at dose of inhaled steroid appropriate to severity of disease.appropriate to severity of disease.
* BDP or equivalent* BDP or equivalent†† Higher nominal doses may beHigher nominal doses may be required if drug delivery is difficultrequired if drug delivery is difficult
Stepwise management ofStepwise management ofasthma in children asthma in children under 5 yearsunder 5 years
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 3: Add-on therapyStep 3: Add-on therapy
In children aged 2-5 years consider addition of leukotriene In children aged 2-5 years consider addition of leukotriene receptor antagonistreceptor antagonist
In children under 2 years consider proceeding to step 4In children under 2 years consider proceeding to step 4
Step 1: Mild intermittent asthma
Step 2: Regular preventer therapy
Step 3: Add-on therapy
Step 2: Regular preventer therapy
Stepwise management ofStepwise management ofasthma in children asthma in children under 5 yearsunder 5 years
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 4: Persistent poor controlStep 4: Persistent poor control
Refer to respiratory paediatricianRefer to respiratory paediatrician
Step 1: Mild intermittent asthma
Stepwise management ofStepwise management ofasthma in children asthma in children under 5 yearsunder 5 years
Pharmacological management. Thorax 2003; 58 (Suppl I): i1-i92
Step 1: Mild intermittent asthmaStep 1: Mild intermittent asthma
Step 4: Persistent poor controlStep 4: Persistent poor control
Step 3: Add-on therapyStep 3: Add-on therapy
Step 2: Regular preventer therapyStep 2: Regular preventer therapy
Stepping downImportant to review patients regularly as they step down
Patients should be maintained at the lowest possible
dose of inhaled steroids
Reductions should be considered every 3 months
Reducing the dose by 25-50% each time
Asthma Management
Exercise Induced AsthmaOften indicates poorly controlled asthma
For patients taking inhaled steroids add:
LABA
LTRAs
Cromones
Oral B2 agonist
Theophylline
Inhaled short acting B2 agonists immediately before
exercise
Asthma Management
Seasonal asthmaStart prophylactic steroid therapy before season begin
Asthma Management
Exacerbations
Occasional attacks between period of good control which can predicted by warning signs
Asthma Management
Exacerbations
warning signs
Increase symptomsSleep disturbanceFall in exercise toleranceIncrease need for bronchodilator Decrease effectiveness of bronchodilatorfalling PEFwide variations in PEFinability to achieve optimum PEF after B agonist
Asthma Management
Exacerbations
Asthma Management
Management of exacerbationsProvide emergency supply oral steroids (Rescue
Course) → to take at the 1st warning sign
seek medical help
written action plan
Time spent with patient for “What to do and
When” will help prevent acute attack
Asthma Management
Rescue course oral steroid20 mg Children 2-5 years
30-40 mg Children >5 y ↨3 days *The dose should be repeated if child vomited
40-50 mg Adult: 5 days or until recovery
Asthma Management
When do you stop medication?
Asthma Management
When do you stop medication?
Adult with stable asthma is possible to reduce inhaled steroids without losing control
On average step down gradually by 25% (Hawkins et al 2003)
Keep patient under regular review even when well controlled
Asthma Management
How do you know if a child is growing out of well controlled asthma if the prophylactic therapy is never reduced for a trial period?
Often patients stops medications themselves when they are betterReducing treatment gradually to the minimum dose possible before medication is stoppedNo exacerbationsNo symptomsNo B 2 useIf symptoms recur medications should be restarted.
Asthma Management